← Leaderboards
Nicholas R Ferreri
New York Medical College
$6,675,603
Attributed
$6,675,603
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $533K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,675,603 · 6
By mechanism
R01$6,311,243 · 4
R21$246,000 · 1
R03$118,360 · 1
Top collaborators
No co-investigators on record.
Most similar at New York Medical College
Same institution · by research overlap
- Michal Laniado Schwartzman$18,004,835
- Wen-Hui Wang$15,197,949
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineExhibitsRegulationSodium ChlorideHypertensionBlood Pressure RegulationResponseThickBlood PressureProtein IsoformsProductionLimb StructureHomeostasisNephronsExcretory FunctionRenal FunctionKidneyGeneticAttenuatedAffectCell TypeS LoopRisk FactorsSalt Intake
Grant awards (24)
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$410,000
R01 · FY2024 · HL · contact PI
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$84,700
R01 · FY2024 · HL · contact PI
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$410,000
R01 · FY2023 · HL · contact PI
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$84,700
R01 · FY2023 · HL · contact PI
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$20,885
R01 · FY2023 · HL · contact PI
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$410,000
R01 · FY2022 · HL · contact PI
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha$410,000
R01 · FY2021 · HL · contact PI
Thick ascending limb-derived TNF, salt sensitivity, and blood pressure regulation$410,000
R01 · FY2019 · HL · contact PI
TNF-UMOD interactions and susceptibility to salt-induced hypertension$123,000
R21 · FY2019 · HL · contact PI
Thick ascending limb-derived TNF, salt sensitivity, and blood pressure regulation$410,000
R01 · FY2018 · HL · contact PI
TNF-UMOD interactions and susceptibility to salt-induced hypertension$123,000
R21 · FY2018 · HL · contact PI
Thick ascending limb-derived TNF, salt sensitivity, and blood pressure regulation$410,000
R01 · FY2017 · HL · contact PI
Thick ascending limb-derived TNF, salt sensitivity, and blood pressure regulation$410,000
R01 · FY2016 · HL · contact PI
Regulation of Renal TNF Production and Function$397,500
R01 · FY2011 · HL · contact PI
Regulation of Renal TNF Production and Function$397,500
R01 · FY2010 · HL · contact PI
Regulation of Renal TNF Production and Function$397,500
R01 · FY2009 · HL · contact PI
Regulation of Renal TNF Production and Function$396,458
R01 · FY2008 · HL · contact PI
Mechanisms of COX-2 Regulation in the mTAL$313,000
R01 · FY2004 · HL
Mechanisms of COX-2 Regulation in the mTAL$313,000
R01 · FY2003 · HL
Mechanisms of COX-2 Regulation in the mTAL$313,000
R01 · FY2002 · HL
REGULATION OF RENAL CYCLOOXYGENASE-2$40,320
R03 · FY2002 · TW
Mechanisms of COX-2 Regulation in the mTAL$313,000
R01 · FY2001 · HL
REGULATION OF RENAL CYCLOOXYGENASE-2$39,020
R03 · FY2001 · TW
REGULATION OF RENAL CYCLOOXYGENASE-2$39,020
R03 · FY2000 · TW